DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions

Abroad (travel likely)Recruiting

Conditions

Type 1 Diabetes · T1D · Obesity & Overweight · Obesity Type 2 Diabetes Mellitus · Asthma Acute · Asthma (Diagnosis)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Adhera Health (Virtual Participation), Seville, Spain
Contact: Study coordinator (Sara Belón) · studies@adherahealth.com · +1 (831) 345-5357

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity

Type 1 Diabetes (T1D) · Overweight · Obesity

Abroad (travel likely)RecruitingPHASE1

Neuss, Germany

Circadian Mechanisms, Glucose, and CV Risks in T1D

Type 1 Diabetes (T1D)

Abroad (travel likely)Recruiting

Chicago, United States

Tirzepatide Use in People With Obesity and Type 1 Diabetes

Type1diabetes · Obesity

Abroad (travel likely)RecruitingPHASE4

Kuwait City, Kuwait

Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes

Diabetes

Abroad (travel likely)RecruitingPHASE2

Tanta, Egypt